This session delves into the evolving landscape of copay accumulator adjustment programs, a pressing issue impacting commercial patient assistance.

This presentation will highlight five common mistakes sterile compounding facilities make when implementing in-house viable sampling and incubation processes.

With a growing number of biosimilars available and interchangeable options emerging, this session explores what the future holds for these innovative therapies.

This presentation will focus on evaluating stability studies of parenteral drugs as a vital step in determining an appropriate BUD for CSPs.

This activity will delve into the essential traits and characteristics that modern healthcare leaders need to thrive in such a dynamic environment.

In the home and alternate site care settings, the perception of high-risk patients often centers on the complexity of the drug or therapy being administered, such as parenteral nutrition (PN) or pain management. However, the growing complexity of patients in these settings necessitates a broader view of risk factors, including co-morbidities, psychosocial challenges, and mental health conditions.

This activity will explore the unique dynamics of the patient/home infusion clinician relationship, emphasizing the challenges that arise in maintaining professional boundaries.